APOGENIX
Apogenix is a clinical stage biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases. The compound´s mechanism of action is either based on the targeted modulation of the programmed cell death (a.k.a. apoptosis - ἁπόπτωσισ is used in Greek to describe the "falling off" of leaves from trees) or on the inhibition of tumour cell growth. The lead product candidate of the company, APG101, is currently in a controlled phase II proof of concept study with GBM patients (GBM: Glioblastoma multiforme).
APOGENIX
Industry:
Biotechnology Health Care Therapeutics
Founded:
2005-01-01
Address:
Heidelberg, Baden-Wurttemberg, Germany
Country:
Germany
Website Url:
http://www.apogenix.com
Total Employee:
51+
Status:
Active
Contact:
+49 6221 58608-0
Total Funding:
38 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro COVID-19 Joomla!
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Amicus Therapeutics
Amicus Therapeutics is a biopharmaceutical company developing therapies for the treatment of rare and orphan diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Ascletis
Ascletis is a specialty therapeutics company developing therapeutics for the treatment of cancer and infectious diseases.
Biomica
Biomica is a biopharmaceutical company that develops microbiome-based therapeutics to treat immune-mediated and infectious diseases.
GeNeuro
GeNeuro is a clinical stage pharmaceutical company developing a new approach to the treatment of autoimmune diseases.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Nanobiotix
Nanobiotix is a nanomedicine company developing novel therapeutics for the local treatment of cancer.
Neovacs
Neovacs, a biotech company, develops several therapeutic vaccines for the treatment of AIDS, cancer and auto-immune and allergic diseases.
Oncodesign
Oncodesign develops anticancer therapies for the treatment of patients with cancer.
Current Advisors List
Board_member
Current Employees Featured
Peter Willinger CFO @ Apogenix
CFO
2015-04-01
Thomas Hoeger Chief Executive Officer @ Apogenix
Chief Executive Officer
2015-12-01
Founder
Investors List
German Federal Ministry of Education and Research
German Federal Ministry of Education and Research investment in Grant - Apogenix
dievini Hopp Biotech Holding
dievini Hopp Biotech Holding investment in Series C - Apogenix
dievini Hopp Biotech Holding
dievini Hopp Biotech Holding investment in Series B - Apogenix
Official Site Inspections
http://www.apogenix.com Semrush global rank: 10.13 M Semrush visits lastest month: 257
- Host name: 213.160.74.20
- IP address: 213.160.74.20
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Apogenix"
Company Profile ǀ Apogenix
The Apogenix team has developed a promising portfolio of innovative immuno-oncology therapeutics for the treatment of cancer and viral infections. Apogenix' drug candidates target …See details»
Apogenix - Crunchbase Company Profile & Funding
Apogenix is a clinical stage biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases. The compound´s mechanism of action is …See details»
Apogenix 2025 Company Profile: Valuation, Funding & Investors
Apogenix General Information Description. Developer of immuno-oncology therapeutics designed to treat cancer and other malignant diseases. The company's platform targets critical …See details»
Management Board - Apogenix
Thomas Hoeger, Ph.D., has been Chief Executive Officer of Apogenix since November 2005. He also oversees the preclinical and clinical development departments at Apogenix. Previously, …See details»
Apogenix ǀ Immuno-oncology therapeutics for the treatment of …
The Apogenix team has created the HERA-ligand technology platform for the development of novel receptor agonists that target different TNFSF-dependent signaling pathways, which play …See details»
Apogenix Company Profile - Office Locations, Competitors ... - Craft
Apogenix has 5 employees at their 1 location and $55.72 m in total funding,. See insights on Apogenix including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Apogenix - Overview, News & Similar companies | ZoomInfo.com
Apogenix is a private company developing innovative immuno-oncology therapeutics for the treatment of solid tumors and hematological malignancies. The company's pipeline of immuno …See details»
Apogenix - Funding, Financials, Valuation & Investors - Crunchbase
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases. Search Crunchbase. ... How much funding has this …See details»
Apogenix - Crunchbase
Apogenix is a biopharmaceutical company developing novel protein therapeutics for the treatment of cancer and inflammatory diseases.See details»
Apogenix AG - Drug pipelines, Patents, Clinical trials - Synapse
Explore Apogenix AG with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 31 news, and 1 literature, Disease Domain:Hemic and Lymphatic Diseases, Infectious …See details»
Apogenix Company Profile: Overview and Full News Analysis
Apogenix is a commercial company located in Baden-Wurttemberg that specializes in immuno-oncology therapeutics for the treatment of cancer and other malignant diseases. ... The trial …See details»
Apogenix AG - BIO CEO & Investor Conference | BIO
Feb 7, 2023 Apogenix is a private company developing innovative immunotherapeutics for the treatment of cancer and viral infections, such as COVID-19. The company’s pipeline of …See details»
Nachrichten über apogenix - Startbase
Nachrichten über apogenix. Umfassende Startup-Listen: Startups aus Heidelberg Startups aus Baden-Württemberg Startups aus Deutschland. Die neusten Erwähnungen von apogenix in …See details»
Apogenix - Contacts, Employees, Board Members, Advisors
Organization. Apogenix . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... Contacts 4. About. Apogenix has 2 current employee …See details»
Apogenix Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Apogenix. See Apogenix company profile and funding data.See details»
Careers ǀ Apogenix
Apogenix develops innovative immunotherapeutics for the treatment of cancer and viral infections, such as COVID-19. Based on a proprietary technology platform, the company has developed …See details»
What is Apogenix? Company Culture, Mission, Values
See what employees say it's like to work at Apogenix. Salaries, reviews, and more - all posted by employees working at Apogenix.See details»
Pipeline ǀ Apogenix
Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant …See details»
Immuno-Oncology Overview - Apogenix
Immuno-oncology therapeutics are believed to be the future of cancer therapy, and Apogenix is at the forefront of this development. Apogenix’ innovative protein therapeutics will work well as …See details»
Press Releases - Apogenix
Jul 28, 2020 Apogenix Granted PRIME Designation by European Medicines Agency for Asunercept to Treat Glioblastoma. April 26, 2017 Apogenix to Present at Three Upcoming …See details»